Cargando…

Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot

BACKGROUND: Endoscopic surveillance is recommended for patients with Barrett's oesophagus because, although the progression risk is low, endoscopic intervention is highly effective for high-grade dysplasia and cancer. However, repeated endoscopy has associated harms and access has been limited...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pilonis, Nastazja Dagny, Killcoyne, Sarah, Tan, W Keith, O'Donovan, Maria, Malhotra, Shalini, Tripathi, Monika, Miremadi, Ahmad, Debiram-Beecham, Irene, Evans, Tara, Phillips, Rosemary, Morris, Danielle L, Vickery, Craig, Harrison, Jon, di Pietro, Massimiliano, Ortiz-Fernandez-Sordo, Jacobo, Haidry, Rehan, Kerridge, Abigail, Sasieni, Peter D, Fitzgerald, Rebecca C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lancet Pub. Group 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803607/ https://www.ncbi.nlm.nih.gov/pubmed/35030332 http://dx.doi.org/10.1016/S1470-2045(21)00667-7

Ejemplares similares

Use of Cytosponge as a triaging tool to upper gastrointestinal endoscopy during the COVID-19 pandemic
por: di Pietro, Massimiliano, et al.
Publicado: (2020)

Detecting Barrett oesophagus using Cytosponge
por: Hindson, Jordan
Publicado: (2020)

The utility of P53 immunohistochemistry in the diagnosis of Barrett's oesophagus with indefinite for dysplasia
por: Januszewicz, Wladyslaw, et al.
Publicado: (2022)

Acceptability of the Cytosponge procedure for detecting Barrett's oesophagus: a qualitative study
por: Freeman, Madeleine, et al.
Publicado: (2017)

Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial
por: Fitzgerald, Rebecca C, et al.
Publicado: (2020)

Barrett’s oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux
por: Offman, Judith, et al.
Publicado: (2018)

Methylation panel is a diagnostic biomarker for Barrett’s oesophagus in endoscopic biopsies and non-endoscopic cytology specimens
por: Chettouh, Hamza, et al.
Publicado: (2018)

Real-world implementation of non-endoscopic triage testing for Barrett’s oesophagus during COVID-19
por: Landy, R, et al.
Publicado: (2023)

Cytosponge-TFF3 Testing can Detect Precancerous Mucosal Changes of the Stomach
por: Hadjinicolaou, ANDREAS V., et al.
Publicado: (2022)

Predictors of the experience of a Cytosponge test: analysis of patient survey data from the BEST3 trial
por: Ghimire, Bhagabati, et al.
Publicado: (2023)

Patient-reported experiences and views on the Cytosponge test: a mixed-methods analysis from the BEST3 trial
por: Maroni, Roberta, et al.
Publicado: (2022)

Endoscopic Management of Dysplastic Barrett’s Oesophagus and Early Oesophageal Adenocarcinoma
por: Eusebi, Leonardo Henry, et al.
Publicado: (2023)

The risk of neoplasia in patients with Barrett's esophagus indefinite for dysplasia: a multicenter cohort study
por: Phillips, Richard, et al.
Publicado: (2021)

Role of body composition and metabolic profile in Barrett’s oesophagus and progression to cancer
por: Di Caro, Simona, et al.
Publicado: (2016)

Economic evaluation of Cytosponge®-trefoil factor 3 for Barrett esophagus: A cost-utility analysis of randomised controlled trial data
por: Swart, Nicholas, et al.
Publicado: (2021)

Acceptability and accuracy of a non-endoscopic screening test for Barrett’s oesophagus in primary care: cohort study
por: Kadri, Sudarshan R, et al.
Publicado: (2010)

Update on endoscopic treatment of Barrett’s oesophagus and Barrett’s oesophagus–related neoplasia
por: Pech, Oliver, et al.
Publicado: (2020)

Barrett's oesophagus and adenocarcinoma
por: Caygill, Christine PJ, et al.
Publicado: (2004)

Management of Barrett's oesophagus
por: Mannath, Jayan, et al.
Publicado: (2009)

Radiofrequency ablation for Barrett’s oesophagus related neoplasia with the 360 Express catheter: initial experience from the United Kingdom and Ireland—preliminary results
por: Magee, Cormac G., et al.
Publicado: (2021)

Use of a non-endoscopic immunocytological device (Cytosponge™) for post chemoradiotherapy surveillance in patients with oesophageal cancer in the UK (CYTOFLOC): A multicentre feasibility study
por: Jones, Christopher M., et al.
Publicado: (2022)

Diagnosis and management of Barrett’s oesophagus
por: Jankowski, Janusz, et al.
Publicado: (2010)

The metaplastic mosaic of Barrett’s oesophagus
por: Biswas, Sujata, et al.
Publicado: (2018)

Barrett’s oesophagus: Current controversies
por: Amadi, Chidi, et al.
Publicado: (2017)

Confocal endomicroscopy diagnostic criteria for early signet-ring cell carcinoma in hereditary diffuse gastric cancer
por: Pilonis, Nastazja D., et al.
Publicado: (2023)

Impact of Barrett oesophagus diagnoses and endoscopies on oesophageal cancer survival in the UK: A cohort study
por: Offman, Judith, et al.
Publicado: (2021)

Monitoring the premalignant potential of Barrett's oesophagus'
por: Graham, David, et al.
Publicado: (2016)

Screening for Barrett's oesophagus: is now the time?
por: Hanada, Yuri, et al.
Publicado: (2020)

Screening for Barrett’s Oesophagus: Are We Ready for it?
por: Yusuf, Aisha, et al.
Publicado: (2021)

Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR study
por: Xu, Yiwang, et al.
Publicado: (2019)

A88 EVALUATING THE ACCEPTABILITY AND EFFICACY OF CYTOSPONGE FOR BARRETT'S ESOPHAGUS: A SINGLE CENTRE CROSS-SECTIONAL STUDY
por: Alqattan, A E, et al.
Publicado: (2023)

Machine Learning Creates a Simple Endoscopic Classification System that Improves Dysplasia Detection in Barrett's Oesophagus amongst Non-expert Endoscopists
por: Sehgal, Vinay, et al.
Publicado: (2018)

Quantification of TFF3 expression from a non-endoscopic device predicts clinically relevant Barrett's oesophagus by machine learning
por: Berman, Adam G., et al.
Publicado: (2022)

Metallothionein in human oesophagus, Barrett's epithelium and adenocarcinoma
por: Coyle, P, et al.
Publicado: (2002)

Influence of Life Style Factors on Barrett's Oesophagus
por: Horna Strand, A., et al.
Publicado: (2014)

Oesophageal xanthalasma with Barrett’s Oesophagus and Menetrier’s Disease
por: Mason, A, et al.
Publicado: (2011)

Genetic progression of Barrett's oesophagus to oesophageal adenocarcinoma
por: Gregson, Eleanor M, et al.
Publicado: (2016)

Extrachromosomal DNA in the cancerous transformation of Barrett’s oesophagus
por: Luebeck, Jens, et al.
Publicado: (2023)

Evaluation of a Minimally Invasive Cell Sampling Device Coupled with Assessment of Trefoil Factor 3 Expression for Diagnosing Barrett's Esophagus: A Multi-Center Case–Control Study
por: Ross-Innes, Caryn S., et al.
Publicado: (2015)

Quality of life measures in dysplastic Barrett’s oesophagus are comparable to patients with non-dysplastic Barrett’s oesophagus and do not improve after endoscopic therapy
por: Ratcliffe, Elizabeth, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3numlnjglrnudp6q845vna3ovd